( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
826.1
811.7
978.4
1455.6
Total Expenditure
2427.2
1702.4
1679.3
1854.8
PBIDT (Excl OI)
-1601.1
-890.7
-700.9
-399.2
Other Income
155.8
91.6
153.9
118.5
Operating Profit
-1445.3
-799.1
-547
-280.7
Interest
206
190.1
177.3
70.6
Exceptional Items
-25
-222.9
NA
NA
PBDT
-1676.3
-1212.1
-724.3
-351.3
Depreciation
185
177.7
157.3
155
Profit Before Tax
-1861.3
-1389.8
-881.6
-506.3
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-1048.6
-1057.9
-694.3
-448.3
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
108.4
-737.4
-141.5
-246.1
Minority Interest
54.5
24.6
20.8
16.1
Shares of Associates
-54.5
-15.7
-36.7
-24.7
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
108.4
-728.5
-157.4
-254.7
Equity Capital
1116.9
1116.9
1116.9
1116.9
Face Value (IN RS)
10
10
10
10
Calculated EPS
0.97
-6.52
-1.40
-2.28
Calculated EPS (Annualised)
3.88
-26.09
-5.63
-9.12
No of Public Share Holdings
55616080
55616080
55616080
55616080
% of Public Share Holdings
49.79
49.79
49.79
49.79
PBIDTM% (Excl OI)
-193.81
-109.73
-71.63
-27.42
PBIDTM%
-174.95
-98.44
-55.90
-19.28
PBDTM%
-202.91
-149.32
-74.02
-24.13
PBTM%
-225.31
-171.22
-90.10
-34.78
PATM%
-126.93
-130.33
-70.96
-30.79